According to a recent LinkedIn post from Zeto Inc, researchers at UT MD Anderson Cancer Center are exploring how music may help address cancer-related fatigue, anxiety, burnout, and so‑called “chemo brain.” The post notes early findings that reportedly include a 270% increase in gamma wave activity linked to cognition and memory, along with increased alpha waves associated with deep relaxation during certain musical pieces.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that Zeto is involved in this research by helping measure real-time brain activity in these clinical settings. For investors, this participation may signal Zeto’s strategy to align its EEG and neuro-monitoring technology with oncology and mental health research, potentially broadening future clinical use cases and strengthening the company’s positioning in evidence-based brain health applications.
The post suggests that, if this line of research progresses and produces robust clinical outcomes, it could support demand for precise, user-friendly brain monitoring solutions in both hospital and research environments. While no commercial agreements or revenue implications are mentioned, the association with a leading cancer center may enhance Zeto’s credibility with key opinion leaders and could create longer-term opportunities for clinical validation and partnership-driven growth.